No Data
No Data
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Teva Pharmaceutical Indus (NYSE:TEVA) has outperformed the market over the past 5 years by 4.1% on an annualized basis producing an average annual return of 16.96%. Currently, Teva Pharmaceutical
Teva's Migraine Treatment Found Effective For Children As Young As 6
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced on Thursday topline results from its Phase 3 SPACE study evaluating the efficacy of Ajovy (fremanezumab) for the prevention of episodic
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for
Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Fortinet, Inc. (NASDAQ:FTNT) is not his favorite. He added that we own Palo Alto Networks, Inc. (NASDAQ:PANW) for the charitable trust.On July 11
Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
Teva Pharmaceutical Indus (NYSE:TEVA) has outperformed the market over the past 5 years by 3.91% on an annualized basis producing an average annual return of 17.49%. Currently, Teva Pharmaceutical
$100 Invested In Nova 15 Years Ago Would Be Worth This Much Today
Nova (NASDAQ:NVMI) has outperformed the market over the past 15 years by 31.68% on an annualized basis producing an average annual return of 44.21%. Currently, Nova has a market capitalization of $6.9